MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2017 International Congress

    Depression among Inpatients with Huntington’s Disease: Patient Characteristics and Outcomes

    F.S. Benesh, S. Gupta, V. Sung (Birmingham, AL, USA)

    Objective: To better understand the relationship between Huntington’s Disease and depression. Background: Huntington’s Disease (HD) is an uncommon genetic neurodegenerative disorder in the United States…
  • 2017 International Congress

    Riding the puzzle: deep brain stimulation and the non-motor symptoms in Parkinson’s disease

    A.C. Campos, E. Talamoni Fonoff, C. Hamani, R. Lima Pagano (São Paulo, Brazil)

    Objective: To better understand the benefits of DBS in non-motor symptoms. Background: Parkinson's disease(PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons,…
  • 2017 International Congress

    Essential Tremor and Depression

    S. Aslam, N. Zhang, C. Adler, J. Caviness, E. Driver-Dunckley, S. Mehta, M. Sabbagh, T. Beach, H. Shill (Phoenix, AZ, USA)

    Objective: To determine if depression and neuropsychiatric symptoms are more prevalent in patients with essential tremor (ET) compared with non-ET controls and if so, to establish…
  • 2017 International Congress

    Cardiovascular autonomic dysfunction, depression and cognitive disorders in Parkinson’s disease patients

    A. Guekht, M. Lebedeva, G. Popov, A. Yakovlev, O. Davidov (Moscow, Russian Federation)

    Objective: The aim of the study was to determine the relationship between depression, cognitive disorders and autonomic regulation of the cardiovascular system in patients with…
  • 2017 International Congress

    Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

    J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

    Objective: To determine whether Parkinson's disease patients with mild cognitive impairment (PD-MCI) demonstrate more accurate self-appraisals of their cognitive deficits than non-PD individuals with amnestic…
  • 2017 International Congress

    Neuroanatomical correlates of depressive symptoms in newly diagnosed Parkinson’s disease patients

    S.J. Kim (Busan, Republic of Korea)

    Objective: Depression is the most frequent neuropsychiatric manifestation in Parkinson's disease (PD). Although evidence suggests that depression in PD is related to the degenerative process…
  • 2017 International Congress

    Psychogenic abdominal myoclonus in Pregnancy: Case Report

    D. García, P.O. Vargaz, Z. Lopez (Toluca de Lerdo, Mexico)

    Objective: Movement disorders in pregnancy represent a diagnostic challenge due to the poor physiopathological understanding in the extrapyramidal system where the afferent and efferent circuits…
  • 2017 International Congress

    Sleepiness and depression in Korean patients with Parkinson’s disease treated with ropinirole and levodopa

    S.Y. Kang, H.-S. Ryu, M.-K. Sunwoo, S.-J. Kim, J.-S. Baik, M.-Y. Park, H.-E. Park, J.-S. Kim, K.-Y. Kwon, S.-B. Koh, Y.-E. Kim, M.-K. Lee, J.-M. Kim, S.J. Chung, Y.-H. Sohn (Hwaseong, Republic of Korea)

    Objective: We aimed to investigate the effect of ropinirole on excessive daytime sleepiness (EDS) and depression in Parkinson’s disease (PD) with large population. Background: EDS…
  • 2017 International Congress

    Neuroticism and depression is associated with impulse control disorder in Parkinson’s disease: a controlled study

    N. Titova, N. Sotnikova, E. Katunina (Moscow, Russian Federation)

    Objective: Cross-sectional assessment of personality trait, impulsivity, depression and anxiety collected prospectively in Parkinson’s disease (PD) with impulse control disorders (PD-ICD) compared to a matched…
  • 2017 International Congress

    Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

    C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

    Objective: Investigate the potential of tozadenant (TOZ) to alleviate the non-motor symptoms of Parkinson's disease using multiple animal models. Background: TOZ is an oral, selective…
  • « Previous Page
  • 1
  • …
  • 24
  • 25
  • 26
  • 27
  • 28
  • …
  • 32
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • An atypical and interesting feature of Parkinson´s disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • #23812 (not found)
  • Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time
  • Application of the “5-2-1” Screening Criteria in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel: Interim Analysis from the DUOGLOBE Study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Decision-making process for opicapone’s bedtime regimen
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley